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A utosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations to either PKD1 or PKD2 genes encoding polycystin-1 (PC1) or polycystin-2 (PC2), respectively. PC1 is a plasma membrane receptor-like protein that has functions in cell-cell or cell-extracellular matrix interactions. PC2 is a nonselective cation channel protein with a large single-channel conductance and high permeability to calcium (Ca 2ϩ ). PC1 interacts with PC2. Their interaction can form a functional receptor-ion-channel-complex and regulate heterotrimeric G-protein-mediated signaling cascades. The mutations of either gene cause a nearly identical clinical phenotype (see review 1 ) .
Cardiovascular complications are the leading cause of mortality and morbidity in ADPKD. The incidence of intracranial aneurysms/aneurysmal ruptures and thoracic aortic dissections in ADPKD is approximately 10-fold higher than in the general population. 2 Even during the early stages of ADPKD, before the onset of hypertension or renal dysfunction, abnormal thickening of the intrarenal arteries and reduction in renal blood flows are evident. 3, 4 Although clinical and experimental evidence indicate a close relation between PKD/Pkd mutations and vascular complications, their pathogenesis is not understood. We have shown that when induced to develop hypertension, Pkd2 ϩ/Ϫ mice have an increased susceptibility to vascular injury, manifested as premature death or developing prominent irregular thickening in the tunica media layer of intracranial vessels. 5 The areas of irregular vessel wall thickening are correlated with abnormally increased or decreased number of VSMCs, indicating an imbalance between smooth muscle cellular proliferation and apoptosis.
Elevated rates of proliferation and apoptosis are the major phenotypic features of ADPKD cells; these abnormalities have been detected in multiple organ systems including kidneys, lungs, liver, heart, brain, spleen, thymus, and testis. 6, 7 Recent studies suggest that reduced basal intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and elevated intracellular cyclic 3Ј:5Ј-adenosine monophosphate (cAMP) play a role in this phenotype. Cystic renal tissues have elevated intracellular cAMP. 8, 9 In contrast to its growth inhibitory effect on wild-type renal epithelial cells, cAMP promotes proliferation in PKD/Pkd mutant renal epithelial cells. 10 -12 This proliferative response to cAMP can also be induced in wild-type renal epithelial cells by reducing their basal [Ca 2ϩ ] i , 13 indi-cating a tight link between reduced [Ca 2ϩ ] i and elevated cAMP to the abnormal proliferation in PKD/Pkd mutant epithelial cells. The mechanism underlying an increased rate of apoptosis is less understood. Studies have shown that a vasopressin (V2) receptor blocker, by blocking adenylyl cyclases (AC) and reducing renal cAMP content, inhibits cyst growth in animal models of PKD. This effect is accompanied by a marked reduction in apoptosis, suggesting that the elevated cellular cAMP contributes to the increased apoptosis in cystic renal epithelial cells. 8, 9 Information regarding cAMP content in Pkd mutant VSMCs and its effect on the VSMC phenotype is lacking. Previously, we have shown that Pkd2 ϩ/Ϫ VSMCs have a significant reduction in PC2 expression and basal [Ca 2ϩ ] i compared with those of wild-type VSMCs. 5 
Materials and Methods

Genotyping, Isolation of the Thoracic Aortas from Adult Mice, and Generation of Cultured VSMCs
These methods were reported. 5, 14, 15 All animal experiments were approved by the Institutional Animal Care and Use Committee. VSMCs were isolated using a commercial kit (Papain dissociation system, Worthington Biochemical) following the manufacturer protocol. Dissociated VSMCs were transferred into culture flasks containing DMEM (10% FCS), incubated at 37°C with 5% CO 2 , and the media changed every other day until the cells reached confluence. The purity of the VSMCs was confirmed both by morphological observation of the SMC-specific hill-and-valley growth pattern and homogeneous staining with smooth muscle ␣-actin mAB that distinguishes SMCs from fibroblasts as described previously. 15 
cAMP Concentration in Tissues and Cells
Vascular smooth muscles or primary cultured VSMCs were lysed in 10 volumes of 5% TCA, pelleted by centrifugation (600g ϫ10 minutes), and supernatants collected for cAMP determination using an enzyme immunoassay kit (Sigma). The results were expressed as pmol of cAMP/mg of protein.
Basal [Ca 2؉ ] i Measurements and Recording Techniques
VSMCs (treated or nontreated) grown on coverslides were loaded with fura-2 AM (Molecular Probes) for 30 minutes, rinsed with media, placed under an inverted Nikon Diaphot microscope, and excited at 340 and 380 nm. The emissions were collected by a 510-nm barrier filter, and images were acquired by a Photometric Cool Snap 12-bit digital camera (Roper Scientific). The ratio of fura-2 emissions was calculated every 0.7 seconds. The basal [Ca 2ϩ ] i was acquired for 30 seconds. Post hoc analysis of [Ca 2ϩ ] i was performed using the Metafluor software. [Ca 2ϩ ] i levels in nmol/L were calculated using an in vitro calibration with known free Ca 2ϩ (0 to 1.35 mol/L) and pentapotassium fura-2 (5 mol/L). The linear plot of the log of the [Ca 2ϩ ] versus the log of the 340/380 fluorescence ratio [(RϪR min )/(R max ϪR)ϫ(380 min /380 max )] was plotted following subtraction of unloaded cell and system background at each wavelength.
H-Thymidine Incorporation
Primary cultured VSMCs (85% to 90% confluence, growth arrested ϫ48 hours) were washed in PBS, pulsed with 1 Ci 3 H-Thymidine in media for 3 hours at 37°C, rinsed in ice-cold 10% TCA (3X) and in ddH 2 0 (1X), and lysed with 0.2 mol/L NaOH containing 40 g/mL salmon sperm DNA. Radioactivities of lysates were quantified by liquid scintillation counting. Treated and nontreated VSMCs were studied in parallel and in triplicates.
Fluorescence-Activated Cell Sorting for S Phase and Apoptotic Cells
VSMCs were washed with PBS, reconstituted in PBS and equal amounts of 95% ethanol on ice for 1 hour, rehydrated in PBS, and resuspended in RNAse A solution (1 mg/mL in 0.1% Na ϩ -citrate) at 37°C ϫ 15 minutes. After addition of propidium iodide (100 g/mL of Na ϩ -citrate), the S phase cells were detected by fluorescence activated cell sorting (FACS). An Annexin-V-FLUOS Staining kit (Roche) was used to stain the cell surface phosphotidylserine following the manufacturer's protocol. The positive cells were detected by FACS (Becton Dickinson FAC Scanner, Mayo Core Facilities).
Cellular Protein Fractionation and Western Blot Analysis
Primary cultured VSMCs collected by scrapping were homogenized by a Polytron homogenizer (4°C) in buffer containing (in mmol/L): 10 Tris (pH7.5); 20 KCl; 1 EGTA; 250 sucrose; 1 PMSF and protease inhibitor cocktail (Roche). Post nuclear supernatants (1000g ϫ15 minutes) were further centrifuged (15 000g ϫ20 minutes), the resulting pellets were enriched with mitochondrial proteins, and the resulting supernatants were further centrifuged (100 000g ϫ2 hours). The resulting supernatants represent cytosols. The lack of membrane proteins in cytosolic fraction was confirmed by immunoblotting with the membrane markers (Calreticulin and PC2). Protein content was determined by the Lowry assay (Bio-Rad). Proteins (20 to 40 g) were denatured in 1ϫ sample buffer with 5% 2-mercaptoethanol at 75°to 95°C for 10 minutes, fractionated by SDS-PAGE (Invitrogen), electrotransferred to PVDF membrane, detected with specific antibody, and visualized by Luminal reagent for enhanced chemiluminescence (Santa Cruz).
Statistical Analysis
Data are expressed as meanϮSE. Student t test and two-way ANOVA were used for comparisons between different groups.
Antibodies and Reagents
Antibodies were obtained from Santa Cruz for PCNA (sc-56), ERK1/2 (sc-93), pERK1/2 (sc7383), and B-Raf (sc-166); from Sigma-Aldrich for SM-␣ actin (A2547); from BD Pharmagen for cytochrome c (556433), cleaved C9 (552036), and cleaved C3 (551150); and from R&D systems for Bax (AF820). Unless otherwise specified, all reagents were obtained from Sigma.
Results
Pkd2 ϩ/؊ Vessels Have Increased Cellular cAMP Levels
Kidneys from Pkd2 ϩ/Ϫ , pcy mice and PCK rats have increased intracellular cAMP. To examine whether this is true in Pkd2 ϩ/Ϫ mutant arteries, we measured the cAMP content in the tunica media layer of individual aortas freshly isolated from sex-matched Pkd2 ϩ/Ϫ and wild-type littermates. As shown in Figure 1A , Pkd2 ϩ/Ϫ vascular smooth muscles have significantly higher levels of cAMP compared with the wild type (PϽ0.001), indicating an increased VSM cellular cAMP concentration. ] i was modestly reduced (Ϸ30% reduction) in treated VSMCs (PϽ0.0001), and this level was maintained throughout the duration of the experiments ( Figure 1B ). As shown in Figure 1C , a reduction of [Ca 2ϩ ] i caused a small but highly significant increase in cellular cAMP (Pϭ0.004 and Pϭ0.0007, respectively).
To dissect whether the AC activation and/or the PDE inhibition is responsible for this effect, cAMP was measured after adding forskolin (a prototype-AC activator, 21 10 mol/L) or IBMX (a pan-PDE inhibitor, 300 mol/L) to the VSMCs treated with Verapamil or BAPTA-AM. As shown in Figure 2 , Forskolin further increased cAMP content (PϽ0.0001) up to 20-fold, whereas IBMX did not have a significant additive effect (Pϭ0.98). These results suggest that cAMP accumulation is caused mainly by PDE inhibition. To further determine whether PDE4, the major PDE in VSMCs, is responsible for this effect, cells were treated with a combination of Verapamil and Rolipram (a selective PDE4 inhibitor, 30 mol/L) before cAMP content was measured. As shown in Figure 2 ] i by Ϸ10% to 25%). The number of S phase cells was determined by FACS analyses after 12 and 24 hours of treatments; no increase in proliferation was detected by adding db-cAMP at any of these dosage combinations (see online Figure S1 , in the online data supplement available at http://circres.ahajournals.org). To further determine whether the endogenous cAMP, induced by a low [Ca 2ϩ ] i , contributes to growth inhibition, the proliferative rate was reassessed after the endogenous cAMP was blocked by Rp-cAMP. As shown in Figure 4B , the proliferation was further heightened by adding Rp-cAMP (Pϭ0.017), indicating that endogenous cAMP is also growth inhibitory.
In Pkd mutant or low [Ca 2ϩ ] i wild-type renal epithelial cells, the cAMP-induced proliferation is accompanied by an elevated B-Raf expression. 11, 13 Of the multiple B-Raf isoforms (62 to 95 kDa), only the 95-kDa isoform is known to be associated with cAMP-induced proliferation. 13, 23 To determine whether the lack of proliferation to cAMP is due to a cell type-specific B-Raf expression, total cell lysate from wild-type VSMCs was fractionated and blotted against a polyclonal B-Raf antibody. As shown in Figure 4C , the 95-kDa B-Raf isoform, which was readily detectable in the lysate from the brain, was not detected in VSMCs at baseline or after treatment with Verapamil or BAPTA-AM, with or without exogenous cAMP. Because the proliferative effect of cAMP is 95-kDa B-Raf dependent, the lack of VSMC proliferation to cAMP is likely due to the absence of the 95-kDa B-Raf isoform. The low [Ca 2ϩ ] i -induced VSMC proliferation is therefore independent of cAMP/B-Raf signaling in this cellular system.
Basal [Ca 2؉ ] i Reduction Increased Apoptosis in VSMCs
Apoptosis can be triggered by [Ca 2ϩ ] i reduction in certain cell types 24, 25 ; cystic epithelial cells are known to have elevated mitochondrial-mediated apoptosis. 26 We hypothesized that the decreased [Ca 2ϩ ] i in VSMCs leads to mitochondrialmediated apoptosis. This hypothesis was tested by determining the apoptotic activities in wild-type VSMCs treated with Verapamil or BAPTA-AM (Ϸ30% reduction in [Ca 2ϩ ] i ) and comparing them to nontreated VSMCs in parallel experiments. We found that the apoptosis was significantly increased by DAPI-nuclear staining (see online Figure S2 ) as well as the FACS analysis staining with Annexin-V for phosphotidylserine, an early cell-surface marker of apoptosis ( Figure 5 , top left, black bars). Three separate experiments, each in triplicate, with either Verapamil or BAPTA-AM, produced nearly identical results (Pϭ0.0001 and Pϭ0.0006, respectively). Quantitative Western analyses for the cellular apoptotic indicators were also performed. As shown in Figure  5, Our first set of experiments show that Pkd2 ϩ/Ϫ mutant vascular smooth muscles contain a higher level of cAMP compared with that of wild-type ones from their littermates ( Figure 1A ). This finding is consistent with the observations in Pkd mutant renal epithelial cells, indicating a commonality in the underlying abnormality associated with Pkd mutations in both systems. Cellular cAMP is synthesized from ATP by ACs (AC1-9) and degraded to 5Ј-ATP by PDEs (PDE1-7) . Because the activities of both can be directly or indirectly affected by diverse factors such as [Ca 2ϩ ] i , Gs/Gi signaling, and ERK signaling, 16, 27, 28 the elevated cAMP content might be a downstream consequence of the [Ca 2ϩ ] i dysregulation associated with Pkd mutations. This hypothesis was tested by determining the changes of cellular cAMP content in wildtype VSMCs after a reduction of [Ca 2ϩ ] i . We found that a modest reduction in basal [Ca 2ϩ ] i (to Ϸ70% of normal) inhibits the activity of PDEs, mainly PDE4 in this primary cultured mice VSMC system, and results in cAMP accumulation ( Figure 1B and 1C) .
The PDE4 family of PDEs is one of the predominant PDEs in VSMCs. 29 They are cAMP-specific and encoded by four genes (PDE4A, PDE4B, PDE4C, and PDE4D); each gene has multiple isoforms resulting from either alternative mRNA splicing or different promoter utilization. Although their activities are not directly modulated by [Ca 2ϩ ] i , 16, 30 there is a complex circuitry of cross talks between ERK and cAMP that affects primarily the PDE4 activities. 28 All four PDE4 (A through D) genes possess FQF and KIM motifs onto which ERK-2 can dock. Furthermore, many widely expressed members of PDE4s, specifically the long forms, possess a C-terminal SPS ERK-consensus motif; the Ser within this motif is specifically phosphorylated by ERK-2. This C-terminal Ser phosphorylation can profoundly inhibit PDE activities and lead to cAMP accumulation. 27, 31, 32 We observed a marked increase in ERK-2 signaling in low [Ca 2ϩ ] i VSMCs accompanying the accelerated cellular proliferation ( Figure 3D ). Therefore, it is conceivable that the PDE4 inhibition under this condition might be due to an ERK-2-mediated PDE4 phosphorylation. Further experiments to confirm this possible mechanism will be a focus of future study.
Cytosolic [Ca 2ϩ ] and cAMP are the two major intracellular second messengers and defects of either can cause abnormal cellular proliferation and/or apoptosis. 25, 33 Our next set of experiments was designed to address whether [Ca 2ϩ ] i reduction leads to an appreciable change in VSMC proliferation. We show that lowering [Ca 2ϩ ] i (to Ϸ70% of normal) by either Verapamil or BAPTA-AM induced a significant increase in VSMC proliferation demonstrated by multiple experimental methods (Figure 3 ). This effect was maintained even when 34 Contrary to these observations, others have reported that L-type Ca 2ϩ channel blockers can inhibit VSMC proliferation induced by insulin or growth factors (IGF-1 or PDGF or FGF), while having no inhibitory effect when applied alone. 35, 36 We believe that the failure to detect a proliferative effect of Ca 2ϩ channel blockers is likely due to the fact that these studies did not investigate or take into account the coexisting apoptosis. The net cell number would not be expected to change significantly if both the proliferative and apoptotic processes are simultaneously activated, as we have shown to be the case when VSMCs were treated with Verapamil. In fact, their results are similar to ours if only the net cell numbers are considered without considering the significantly different rates of apoptosis between the cells with normal and low [Ca 2ϩ ] i . We next determined the effects of cAMP on VSMC proliferation. cAMP is known to inhibit VSMC proliferation and to promote cellular differentiation. 22 Consistent with this observation, we found that cAMP inhibited proliferation in primary cultured wild-type VSMCs ( Figure 4A ). However, in contrast to a proliferative effect observed in low [Ca 2ϩ ] i wild-type and Pkd mutant renal epithelial cells, exogenous cAMP inhibited proliferation of VSMCs with low [Ca 2ϩ ] i . Furthermore, when the endogenous cAMP, induced by PDE inhibition, was blocked by Rp-cAMP, the rate of proliferation was further heightened ( Figure 4B ). These findings indicate that a higher level of cAMP, endogenous or exogenous, is growth inhibitory to VSMCs regardless of their [Ca 2ϩ ] i level.
This opposite cAMP response might be explained by the different patterns of B-Raf expression in VSMCs compared with that of renal epithelial cells. B-Raf is one of the three kinases (c-Raf-1, B-Raf, and A-Raf) that belong to a cytoplasmic serine/threonine kinase family. It has multiple isoforms, 95-kDa and 62 to 77 kDa (splice variants of 95-kDa form lacking the N-terminus). 37 Only the 95-kDa isoform is known to mediate cAMP induced proliferation, in some cells through Rap-1/B-Raf signaling pathway. 23 Although Rap-1 is ubiquitously expressed, B-Raf isoforms have a more cell type-restricted pattern of expression. 37 Although renal epithelial cells express 95-kDa B-Raf, 13,37 the B-Raf isoform expression in VSMCs has not been defined. We show that VSMCs express only the 68-kDa B-Raf; the 95-kDa isoform cannot be detected, nor be induced by decreasing [Ca 2ϩ ] i or increasing cellular cAMP concentration ( Figure 4C ). This finding, compounded with the observation that the proliferative response to cAMP in the Pkd mutant or low [Ca 2ϩ ] i wild-type renal epithelial cells is accompanied by a simultaneous rise in 95-kDa B-Raf isoform, 11, 13 indicates that the lack of 95-kDa B-raf in VSMCs likely accounts for the lack of proliferative response to cAMP.
We have shown that Pkd2 ϩ/Ϫ VSMCs accumulate cAMP; in certain cell types, cAMP triggers apoptosis. 22, 38, 39 Our last set of experiments examined whether the elevated apoptosis can be caused by cellular cAMP accumulation or a low [Ca 2ϩ ] i in VSMCs. We found that cAMP triggers apoptosis in VSMCs with either normal or low [Ca 2ϩ ] i ; this apoptotic process appears mainly via a mitochondrial-mediated mechanism, demonstrated by a concordant increase in the mitochondrial-cytochrome c release and the recruitment of Bax into the mitochondrial fraction. This apoptotic effect was further confirmed by data showing that when endogenous cAMP was blocked, the rate of apoptosis was reverted to near normal range despite the fact that these VSMCs were still maintained in low [Ca 2ϩ ] i condition ( Figure 5 , top left). These results indicate that the elevated cellular cAMP, not the low [Ca 2ϩ ] i , is the main determinant of an accelerated apoptosis. Our findings are in accord with a recent study showing that the reduction in cellular cAMP by upregulating PDE4B in diffuse large B-cell lymphomas causes resistance to chemotherapy-induced apoptosis. This resistance is mediated by a low cAMP concentration, which leads to an increase in PI3 kinase activity and its downstream AKT signaling. 40 Our results show, conversely, a higher VSMC cAMP level triggers apoptosis, likely via the same mechanism, but turning down instead of turning up, the PI3 kinase and AKTmediated survival signaling.
In summary, we have found that (1 
